Granahan Investment Management, LLC Ionis Pharmaceuticals Inc Transaction History

Granahan Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$41.6 - $63.4 $147,097 - $224,182	-3,536 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$53.85 - $65.27 $2,154 - $2,610	-40 Reduced 1.12%	3,536 $214,000
Q3 2019 Nov 15, 2019	BUY	$59.06 - $72.15 $2,067 - $2,525	35 Added 0.99%	3,576 $214,000
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $219,860 - $305,021	3,541 New	3,541 $228,000
Q1 2019 May 14, 2019	SELL	$52.92 - $81.17 $228,402 - $350,329	-4,316 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$42.88 - $53.7 $185,070 - $231,769	4,316 New	4,316 $223,000

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Granahan Investment Management, LLC with notifications on news.